Evaluation of Echinacea Leaf Extract and Allantoin Based Topical Formulations in an Imiquimod-Induced Psoriasis-like Model
Medical Sciences · 01.06.2026 · 14 (2) · 283
DOI: 10.3390/medsci14020283 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Sciences, online erschienen am 01.06.2026. Verfasst von Cristina Burlou-Nagy Fati und 9 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School of Biological and Biomedical Sciences, University of Oradea, Universitatii Str. No 1, 410087 Oradea, Romania. Hauptthemen laut MEDLINE: Allantoin, Plant Extracts, Psoriasis, Echinacea. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Oradea, Oradea, Romania.
Abstract (Originalsprache)
Background/Objectives: Psoriasis is a chronic inflammatory disorder characterized by epidermal hyperproliferation and immune dysregulation. This study evaluated the topical efficacy of Echinacea leaf extract and allantoin compared to a corticosteroid (mometasone furoate) in an imiquimod (IMQ)-induced psoriasis-like model in Sprague-Dawley rats.
Methods
Psoriasiform lesions were induced by daily application of 5% IMQ for six days, followed by six weeks of treatment with one of the following formulations: Echinacea cream or gel, allantoin cream or gel, and mometasone. Disease severity was assessed using a modified Psoriasis Area and Severity Index (PASI) and histological analysis.
Results
All groups developed psoriasis-like lesions; however, Echinacea cream produced the most pronounced and sustained reduction in PASI scores, with near-complete macroscopic recovery. Echinacea gel and allantoin cream showed moderate effects, while allantoin gel and mometasone exhibited limited efficacy. Histological findings supported these results, with Echinacea cream restoring near-normal epidermal architecture.
Conclusions
In conclusion, topical Echinacea leaf extract formulations, particularly the cream formulation, demonstrated superior efficacy in reducing psoriasis-like skin inflammation and restoring epidermal structure compared to allantoin based treatments and mometasone. These findings suggest that Echinacea-derived bioactive compounds may represent promising candidates for the development of alternative or adjunctive therapies for inflammatory skin diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doctoral School of Biological and Biomedical Sciences, University of Oradea, Universitatii Str. No 1, 410087 Oradea, Romania.
- Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, P-ta 1 Decembrie No 10, 410073 Oradea, Romania.
- Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, P-ta 1 Decembrie No 10, 410073 Oradea, Romania.
- Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, Nagyerdei Krt 98, 4032 Debrecen, Hungary.
ORCID-Profile: Cristina Burlou-Nagy Fati, Laura Grațiela Vicaș, Octavia Gligor, Imre Leiter, Rita Kiss
Förderung
- University of Oradea, Oradea, Romania
Zitieren
APA
Fati, C. B., Pallag, A., Vicaș, L. G., Gligor, O., Horvath, T., Lelesz, B., Hegedűs, C., Leiter, I., Juhász, B., & Kiss, R. (2026). Evaluation of Echinacea Leaf Extract and Allantoin Based Topical Formulations in an Imiquimod-Induced Psoriasis-like Model. Medical Sciences, 14(2), 283. https://doi.org/10.3390/medsci14020283
Vancouver
Fati CB, Pallag A, Vicaș LG, Gligor O, Horvath T, Lelesz B, et al. Evaluation of Echinacea Leaf Extract and Allantoin Based Topical Formulations in an Imiquimod-Induced Psoriasis-like Model. Medical Sciences. 2026;14(2):283. doi:10.3390/medsci14020283
BibTeX
@article{Fati2026,
author = {Fati, Cristina Burlou-Nagy and Pallag, Annamaria and Vicaș, Laura Grațiela and Gligor, Octavia and Horvath, Tünde and Lelesz, Beáta and Hegedűs, Csaba and Leiter, Imre and Juhász, Béla and Kiss, Rita},
title = {Evaluation of Echinacea Leaf Extract and Allantoin Based Topical Formulations in an Imiquimod-Induced Psoriasis-like Model},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {2},
pages = {283},
doi = {10.3390/medsci14020283}
}
EUVIMED